Most Read Articles
2 days ago
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 2 days ago
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Christina Lau, 6 days ago

Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.

DCB angioplasty vs DES implantation: Which is better in coronary stent restenosis?

02 Jun 2020

Drug-coated balloon (DCB) angioplasty and repeat stenting with drug-eluting stent (DES) show comparable safety and effectiveness in the treatment of patients with bare-metal stent (BMS) coronary in-stent restenosis (ISR) at 3 years, according to a study.

On the other hand, DCB angioplasty is significantly less effective than repeat DES implantations in the treatment of patients with DES-ISR and correlated with a nonsignificant decrease in the composite of all-cause death, myocardial infarction, or target lesion thrombosis at 3-year follow-up.

The investigators conducted a pooled analysis of individual patient data from all 10 existing randomized clinical trials comparing DCB angioplasty with repeat DES implantation for the treatment of coronary ISR. Patients were stratified in the prespecified analysis according to BMS- vs DES-ISR and treatment assigned.

Target lesion revascularization (TLR) was the primary efficacy endpoint, while the primary safety endpoint was a composite of all-cause death, myocardial infarction, or target lesion thrombosis at 3 years. Mixed-effects Cox models were used for the primary analysis, accounting for the trial of origin.

Overall, 710 patients with BMS-ISR (722 lesions) and 1,248 with DES-ISR (1,377 lesions) were included in the analysis. No significant difference was seen between treatments in patients with BMS-ISR in terms of primary efficacy (9.2 percent vs 10.2 percent; hazard ratio [HR], 0.83, 95 percent confidence interval [CI], 0.51–1.37) and safety endpoints (8.7 vs 7.5 percent; HR, 1.13, 95 percent CI, 0.65–1.96). Results were consistent in secondary analyses.

In patients with DES-ISR, DCB angioplasty showed a higher risk of the primary efficacy endpoint than repeat DES implantation (20.3 percent vs 13.4 percent; HR, 1.58, 95 percent CI, 1.16–2.13) and a numerically lower risk of the primary safety endpoint (9.5 percent vs 13.3 percent; HR, 0.69, 95 percent CI, 0.47–1.00). Secondary analyses results were consistent.

Regardless of the treatment used, TLR risk was lower in BMS- vs DES-ISR (9.7 percent vs 17.0 percent; HR, 0.56, 95 percent CI, 0.42–0.74). On the other hand, no statistical difference was seen between ISR types in terms of safety.

“Overall, DES-ISR is associated with higher rates of treatment failure and similar safety compared with BMS-ISR,” the investigators said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 2 days ago
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Christina Lau, 6 days ago

Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.